Performance of Machine Learning and Texture Analysis for Predicting Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer with 3T MRI

Background: To evaluate the diagnostic performance of a Machine Learning (ML) algorithm based on Texture Analysis (TA) parameters in the prediction of Pathological Complete Response (pCR) to Neoadjuvant Chemoradiotherapy (nChRT) in Locally Advanced Rectal Cancer (LARC) patients. Methods: LARC patients were prospectively enrolled to undergo pre- and post-nChRT 3T MRI for initial loco-regional staging. TA was performed on axial T2-Weighted Images (T2-WI) to extract specific parameters, including skewness, kurtosis, entropy, and mean of positive pixels. For the assessment of TA parameter diagnostic performance, all patients underwent complete surgical resection, which served as a reference standard. ROC curve analysis was carried out to determine the discriminatory accuracy of each quantitative TA parameter to predict pCR. A ML-based decisional tree was implemented combining all TA parameters in order to improve diagnostic accuracy. Results: Forty patients were considered for final study population. Entropy, kurtosis and MPP showed statistically significant differences before and after nChRT in patients with pCR; in particular, when patients with Pathological Partial Response (pPR) and/or Pathological Non-Response (pNR) were considered, entropy and skewness showed significant differences before and after nChRT (all p < 0.05). In terms of absolute value changes, pre- and post-nChRT entropy, and kurtosis showed significant differences (0.31 ± 0.35, in pCR, −0.02 ± 1.28 in pPR/pNR, (p = 0.04); 1.87 ± 2.19, in pCR, −0.06 ± 3.78 in pPR/pNR (p = 0.0005); 107.91 ± 274.40, in pCR, −28.33 ± 202.91 in pPR/pNR, (p = 0.004), respectively). According to ROC curve analysis, pre-treatment kurtosis with an optimal cut-off value of ≤3.29 was defined as the best discriminative parameter, resulting in a sensitivity and specificity in predicting pCR of 81.5% and 61.5%, respectively. Conclusions: TA parameters extracted from T2-WI MRI images could play a key role as imaging biomarkers in the prediction of response to nChRT in LARC patients. ML algorithms can be used to efficiently combine all TA parameters in order to improve diagnostic accuracy.

[1]  F. Bazzoli,et al.  The Heterogeneity of Skewness in T2W-Based Radiomics Predicts the Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer , 2021, Diagnostics.

[2]  H. Alkadhi,et al.  Radiomics in medical imaging—“how-to” guide and critical reflection , 2020, Insights into Imaging.

[3]  I. El Naqa,et al.  Electron Density and Biologically Effective Dose (BED) Radiomics-Based Machine Learning Models to Predict Late Radiation-Induced Subcutaneous Fibrosis , 2020, Frontiers in Oncology.

[4]  Rafał Obuchowicz,et al.  Does image normalization and intensity resolution impact texture classification? , 2020, Comput. Medical Imaging Graph..

[5]  Gary Liney,et al.  Study protocol: multi-parametric magnetic resonance imaging for therapeutic response prediction in rectal cancer , 2017, BMC Cancer.

[6]  Tone F. Bathen,et al.  T2-weighted MRI-derived textural features reflect prostate cancer aggressiveness: preliminary results , 2017, European Radiology.

[7]  Liang Xu,et al.  Application of texture analysis based on apparent diffusion coefficient maps in discriminating different stages of rectal cancer , 2017, Journal of magnetic resonance imaging : JMRI.

[8]  R. Lerski,et al.  Interim heterogeneity changes measured using entropy texture features on T2-weighted MRI at 3.0 T are associated with pathological response to neoadjuvant chemotherapy in primary breast cancer , 2017, European Radiology.

[9]  Vicky Goh,et al.  Primary Rectal Cancer: Repeatability of Global and Local-Regional MR Imaging Texture Features , 2017, Radiology.

[10]  A. Afaq,et al.  Magnetic resonance based texture parameters as potential imaging biomarkers for predicting long‐term survival in locally advanced rectal cancer treated by chemoradiotherapy , 2017, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[11]  B. Ganeshan,et al.  Performance of diffusion-weighted imaging, perfusion imaging, and texture analysis in predicting tumoral response to neoadjuvant chemoradiotherapy in rectal cancer patients studied with 3T MR: initial experience , 2016, Abdominal Radiology.

[12]  C. Liang,et al.  Computed tomography texture analysis to facilitate therapeutic decision making in hepatocellular carcinoma , 2016, Oncotarget.

[13]  Richard Emsley,et al.  Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis. , 2016, The Lancet. Oncology.

[14]  Felix G. Meinel,et al.  Texture Analysis as Imaging Biomarker of Tumoral Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients Studied with 3-T Magnetic Resonance , 2015, Investigative radiology.

[15]  Angelita Habr-Gama,et al.  Watch and Wait Approach Following Extended Neoadjuvant Chemoradiation for Distal Rectal Cancer: Are We Getting Closer to Anal Cancer Management? , 2013, Diseases of the colon and rectum.

[16]  M. P. Hayball,et al.  CT texture analysis using the filtration-histogram method: what do the measurements mean? , 2013, Cancer imaging : the official publication of the International Cancer Imaging Society.

[17]  S. Galimberti,et al.  Locally advanced rectal cancer: value of ADC mapping in prediction of tumor response to radiochemotherapy. , 2013, European journal of radiology.

[18]  Bal Sanghera,et al.  Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice? , 2012, Insights into Imaging.

[19]  Myeong-Jin Kim,et al.  Perfusion MRI for the prediction of treatment response after preoperative chemoradiotherapy in locally advanced rectal cancer , 2012, European Radiology.

[20]  E. Hoffman,et al.  Exploration of the volumetric composition of human lung cancer nodules in correlated histopathology and computed tomography. , 2011, Lung cancer.

[21]  G. Brandi,et al.  Neoadjuvant Treatment in Rectal Cancer: Actual Status , 2011, Chemotherapy research and practice.

[22]  Karin Haustermans,et al.  Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. , 2010, The Lancet. Oncology.

[23]  R. Heald,et al.  RECURRENCE AND SURVIVAL AFTER TOTAL MESORECTAL EXCISION FOR RECTAL CANCER , 1986, The Lancet.

[24]  V. Goh,et al.  Assessment of primary colorectal cancer heterogeneity by using whole-tumor texture analysis: contrast-enhanced CT texture as a biomarker of 5-year survival. , 2013, Radiology.

[25]  O. Dworak,et al.  Pathological features of rectal cancer after preoperative radiochemotherapy , 1997, International Journal of Colorectal Disease.